Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.

Synergism between amoxicillin and clavulanic acid was not expected against cephalosporinase-producing bacterial strains because clavulanic acid has little inhibitory action on cephalosporinases. However, in a clinical trial of BRL 25000 (amoxicillin-clavulanic acid), excellent results were obtained...

Cijeli opis

Bibliografski detalji

Izdano u:	Antimicrob Agents Chemother
Glavni autori:	Nakazawa, H, Hashimoto, T, Nishiura, T, Mitsuhashi, S
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1983
Teme:	Research Article
Online pristup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185341/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6357078/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.24.3.437
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!